N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) is now established for the diagnosis of heart failure, but new evidence also points to the role of NT-proBNP in diagnosing myocardial ischemia in asymptomatic patients for primary prevention. This evidence concerns the gene NPPB and myocardial ischemia.